Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
224 participants
OBSERVATIONAL
2022-11-21
2040-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969
At High-risk for Pre-eclampsia After Assisted Reproductive Technology
NCT05746793
Development of an International Remote Digital Care System for Accessible, Inclusive and Sustainable Pregnancy Care
NCT07191236
Exercise Testing After Preeclampsia
NCT06741436
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home surveillance of pregnancies at risk
Offer women with pregnancies at risk home surveillance instaed of more frequent hospital out-patient visits and/or hospitalisation: cardiotocographia (CTG), patient measurements of CRP, temperature, blood pressure, and clinical signs of infection or severe forms of preeclampsia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational Hypertension
* Premature Preterm Rupture of Membranes
* High Risk Pregnancy
* Previous adverse obstetric outcomes
Exclusion Criteria
* Patient or fetus in immediate need for delivery
* Not understanding Norwegian
* Not mastering the technological aspects of home monitoring
* Long travel distance to Obstetric Department
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Norwegian SIDS and Stillbirth Society
OTHER
University of Oxford
OTHER
Rigshospitalet, Denmark
OTHER
Sykehuspartner
UNKNOWN
Dignio
UNKNOWN
Medexa
UNKNOWN
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Cathrine Staff
Professor, Head of research, MD; PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Cathrine Staff, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Waldum AH, Pay ASD, Aasbo G, Mishra VK, Sugulle M, Staff AC. The HOME (home monitoring of high-risk pregnancies) study: a study protocol for an observational study of a telemedicine-assisted follow-up at home vs. hospitalization. Front Glob Womens Health. 2025 Jul 14;6:1599153. doi: 10.3389/fgwh.2025.1599153. eCollection 2025.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
473099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.